BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rajaram S, Boikos C, Gelone DK, Gandhi A. Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing. Ther Adv Vaccines Immunother 2020;8:2515135520908121. [PMID: 32128506 DOI: 10.1177/2515135520908121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Boikos C, Mcgovern I, Molrine D, Ortiz JR, Puig-barberà J, Haag M. Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons. Vaccines 2022;10:896. [DOI: 10.3390/vaccines10060896] [Reference Citation Analysis]
2 Jordan K, Murchu EO, Comber L, Hawkshaw S, Marshall L, O'Neill M, Teljeur C, Harrington P, Carnahan A, Pérez-Martín JJ, Robertson AH, Johansen K, Jonge J, Krause T, Nicolay N, Nohynek H, Pavlopoulou I, Pebody R, Penttinen P, Soler-Soneira M, Wichmann O, Ryan M. Systematic review of the efficacy, effectiveness and safety of cell-based seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age. Rev Med Virol 2022;:e2332. [PMID: 35137512 DOI: 10.1002/rmv.2332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Divino V, Ruthwik Anupindi V, DeKoven M, Mould-Quevedo J, Pelton SI, Postma MJ, Levin MJ. A Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019-2020 Influenza Season in the United States. Open Forum Infect Dis 2022;9:ofab604. [PMID: 35028334 DOI: 10.1093/ofid/ofab604] [Reference Citation Analysis]
4 Chung YH, Church D, Koellhoffer EC, Osota E, Shukla S, Rybicki EP, Pokorski JK, Steinmetz NF. Integrating plant molecular farming and materials research for next-generation vaccines. Nat Rev Mater 2021;:1-17. [PMID: 34900343 DOI: 10.1038/s41578-021-00399-5] [Reference Citation Analysis]
5 Ortiz de Lejarazu-Leonardo R, Montomoli E, Wojcik R, Christopher S, Mosnier A, Pariani E, Trilla Garcia A, Fickenscher H, Gärtner BC, Jandhyala R, Zambon M, Moore C. Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes-Systematic Literature Review and Expert Consensus. Vaccines (Basel) 2021;9:1255. [PMID: 34835186 DOI: 10.3390/vaccines9111255] [Reference Citation Analysis]
6 Elkashif A, Alhashimi M, Sayedahmed EE, Sambhara S, Mittal SK. Adenoviral vector-based platforms for developing effective vaccines to combat respiratory viral infections. Clin Transl Immunology 2021;10:e1345. [PMID: 34667600 DOI: 10.1002/cti2.1345] [Reference Citation Analysis]
7 Tang CY, Segovia K, McElroy JA, Li T, Guan M, Zhang X, Misra S, Hang J, Wan XF. Cell-Adapted Mutations and Antigenic Diversity of Influenza B Viruses in Missouri, 2019-2020 Season. Viruses 2021;13:1896. [PMID: 34696325 DOI: 10.3390/v13101896] [Reference Citation Analysis]
8 Boikos C, Fischer L, O'Brien D, Vasey J, Sylvester GC, Mansi JA. Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018-2019 Influenza Season in the United States. Clin Infect Dis 2021;73:e692-8. [PMID: 33400775 DOI: 10.1093/cid/ciaa1944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Cai R, Gerlier L, Eichner M, Schwehm M, Rajaram S, Mould-Quevedo J, Lamotte M. Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany. J Med Econ 2021;24:490-501. [PMID: 33761803 DOI: 10.1080/13696998.2021.1908000] [Reference Citation Analysis]
10 Park SH, Ji KY, Kim HM, Ma SH, Park SY, Do JH, Oh DB, Kang HS, Shim JS, Joung YH. Optimization of the human colorectal carcinoma antigen GA733-2 production in tobacco plants. Plant Biotechnol Rep 2021;:1-13. [PMID: 33520002 DOI: 10.1007/s11816-020-00657-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Thompson AJ, Paulson JC. Adaptation of influenza viruses to human airway receptors. J Biol Chem 2021;296:100017. [PMID: 33144323 DOI: 10.1074/jbc.REV120.013309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Stambas J, Lu C, Tripp RA. Innate and adaptive immune responses in respiratory virus infection: implications for the clinic. Expert Rev Respir Med 2020;14:1141-7. [PMID: 32762572 DOI: 10.1080/17476348.2020.1807945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]